World Health Organization (WHO) Representative pays courtesy call on WHO Collaborating Centre for Nursing and Midwifery Development at the University of Botswana School of Nursing
Dr. Ndenzako was welcomed by Professor Magowe, Dean of the Faculty of Health Sciences; Professor Phaladze, Deputy Dean; Dr. Samuel Matula, Head of the School of Nursing; Ms. Mosidi Mokotedi, WHOCC Coordinator; and other faculty members. In her welcome remarks, Prof. Magowe provided an overview of the Faculty of Health Sciences, which encompasses the School of Nursing, School of Allied Health Professions, School of Pharmacy, and School of Public Health. She highlighted that the School of Nursing, established in 1978, is the oldest within the faculty. Its core mission is to produce highly skilled and well-rounded health professionals to serve Botswana, the African continent, and beyond. The school aligns its undergraduate and graduate training with international standards and promotes robust research to inform evidence-based curricula. The faculty also offers graduate programs, including master's and PhD degrees.
Dr. Matula elaborated on the evolution of the School of Nursing, noting that it began as the Department of Nursing Education in 1978 and became a full-fledged school in 2007. The school offers both undergraduate and postgraduate degrees, including the Bachelor of Nursing Science and the Master of Nursing. A PhD programme is also expected to be launched soon. Notably, the Master of Nursing in Gerontology and Palliative Care was introduced in August 2024.
Designated in 1990, the School of Nursing is a WHO Collaborating Centre for Nursing and Midwifery Development in Sub-Saharan Africa. Among its contributions, the school developed a model for home-based care that has been shared regionally. It has played a vital role in introducing nursing education in higher institutions across the East, Central, and Southern Africa (ECSA) region, and has supported the establishment of National Nurses Associations and Nursing and Midwifery Councils. The school has been instrumental in standardizing nursing and midwifery curricula and strengthening regulatory frameworks.
The school is a member of key regional networks such as the Consortium for Higher Education in Nursing and Midwifery in Africa (CHENMA) and the Eastern, Central, and Southern Africa College of Nursing (ECSACON). It has mobilized resources for projects such as the Adolescent Health and HIV/AIDS Project and the Project for Nursing Leadership. Collaborations extend beyond the government to include the University of Pennsylvania, Rutgers University, the University of Michigan, the Cancer Association, and various NGOs.
From 2018 to 2022, the WHOCC focused on strengthening the role of nursing and midwifery in reducing the burden of Non-Communicable Diseases (NCDs), promoting health and wellness across the lifespan, and enhancing maternal, newborn, child, and adolescent health services. These efforts were carried out in collaboration with other WHOCCs, civil society organizations, and development partners.
Under its current designation (March 2022 to February 2026), the WHOCC is working towards three core objectives:
1. Conducting collaborative research on the impact of the COVID-19 pandemic on the nursing and midwifery workforce.
2. Strengthening nursing and midwifery leadership in line with WHO's Strategic Directions for Nursing and Midwifery (2021–2025).
3. Promoting rehabilitative and palliative care services within the context of revitalized Primary Health Care.
Dr. Matula reported notable progress. For the COVID-19-related research, the school conducted literature reviews and co-authored three publications. It also assessed leadership gaps among nurses, with one publication underway. Leadership development efforts included benchmarking training qualifications and materials used in Botswana against international resources, such as those from the South Pacific GNWHOCCNM and Kamuzu University of Health Sciences. A pilot leadership workshop was conducted, and its outcomes documented.
To strengthen rehabilitative and palliative care, a needs assessment was carried out, leading to the development of a specialized Oncology and Palliative Nursing curriculum. Dr. Matula acknowledged that while implementation was delayed by prolonged COVID-19 response efforts and funding constraints, global WHOCC networks and partnerships with communities and stakeholders remain valuable enablers for progress.
In his remarks, Dr. Ndenzako commended the School of Nursing for its 35-year tenure as a WHO Collaborating Centre. He noted that Botswana currently hosts two WHOCCs, the second being the Botswana National HIV Drug Resistance Laboratory, designated in 2023. He praised the school's research outputs and emphasized their importance in informing WHO policies.Dr. Ndenzako highlighted the changing global health financing landscape, which calls for stronger partnerships to advance the health agenda. He encouraged the school to document and publish its 35-year journey to share lessons with other institutions. He reaffirmed WHO's commitment to supporting the WHOCC's continued efforts.
In closing, Dr. Sebego thanked WHO for its ongoing collaboration and underscored the need to sustain and strengthen the partnership.
Distributed by APO Group on behalf of World Health Organization (WHO), Botswana.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
2 days ago
- Zawya
War fuels cholera outbreak across Sudan with Médecins sans frontières (MSF) seeing over 2,300 patients and 40 dead in one week
The worst cholera outbreak Sudan has had in years is currently spreading, fuelled by the ongoing conflict. People are now grappling with the outbreak on top of the all out war they have experienced over two years. In Darfur region alone, MSF teams saw over 2,300 cholera patients, and 40 deaths, in the last week alone. On top of an all out war, people in Sudan are now experiencing the worst cholera outbreak the country has seen in years. First declared by the Ministry of Health one year ago, there has since been 99,700 suspected cases and more than 2,470 related deaths, as of 11 August. In Darfur region alone, Médecins Sans Frontières (MSF) teams treated over 2,300 patients and recorded 40 deaths in the past week for cholera, at facilities run by the Ministry of Health. Across Darfur, cholera is hitting people who already struggled with water shortages that made it impossible to follow essential hygiene measures, such as washing dishes and food. The situation is most extreme in Tawila, North Darfur state, where 380,000 people have fled to escape ongoing fighting around the city of El Fasher, according to the United Nations. By the end of July, after one month of responding, MSF teams treated over 2,300 cholera patients in collaboration with the Ministry of Health in Tawila. The cholera treatment centre at Tawila Hospital, officially equipped with 130 beds, had to accommodate 400 patients during the first week of August, overwhelming the facility and forcing staff to add extra mattresses on the floor to cope. In Tawila, people survive with an average of just three litres of water per day, which is less than half the emergency minimum threshold of 7.5 litres needed per person per day for drinking, cooking, and hygiene, as stipulated by the WHO. As cholera cases rise and resources run out, clean water and sanitation services are urgently needed to prevent more deaths. 'In displacement and refugee camps, families often have no choice but to drink from contaminated sources and many contract cholera,' says Sylvain Penicaud, MSF project coordinator in Tawila. 'Just two weeks ago, a body was found in a well inside one of the camps. It was removed, but within two days, people were forced to drink from that same water again.' About 100 kilometres from Tawila, cholera was reported in Golo, Central Darfur state, on 13 July. MSF opened a 73-bed cholera treatment centre in Golo hospital. This centre was quickly overwhelmed, with 137 patients arriving on 3 August alone. Five oral rehydration points were set up around Golo to manage mild cases and prevent deterioration, but our teams see that the outbreak is still spreading fast. In early August, cholera reached Zalingei and Rokero in Central Darfur state, and Sortony in North Darfur state. Heavy rains are worsening the crisis by contaminating water and damaging sewage systems. Cases are continuing to rise in South Darfur state, as well, where MSF, in coordination with the Ministry of Health, has expanded the cholera treatment centre in Nyala to 80 beds. There, the response is waiting for vaccines and facing a severe shortage of water purification tablets. 'The health centres are full,' says Samia Dahab, a resident of Otash displacement camp in Nyala. 'Some areas have water, others have kiosks that are far or empty. Some water is salty, and we drink it unboiled, unsure if it's safe.' As people move around to flee fighting, cholera is spreading further, in Sudan and into neighbouring Chad and South Sudan. In Damazin, Blue Nile state, Sudan, MSF and the Ministry of Health expanded the Damazin hospital cholera treatment centre from 50 to 250 beds in July to cope with an influx of returnees from South Sudan. At this centre, our teams are seeing a deadly combination of cholera and malnutrition. Between 3 and 9 August, six cholera patients who died were also suffering from acute malnutrition. 'The situation is beyond urgent,' says Tuna Turkmen, MSF's head of mission in Sudan. 'The outbreak is spreading well beyond displacement camps now, into multiple localities across Darfur states and beyond.' 'The international response must have an outbreak emergency coordination mechanism able to provide healthcare, improve water and sanitation services, and begin cholera vaccination campaigns in affected areas at a pace that matches the urgency this catastrophic situation requires,' says Turkmen. 'Every day of delay costs lives. MSF stands ready to collaborate with the Ministry of Health, UNICEF, and WHO to launch mass vaccination campaigns across Darfur. Survivors of war must not be left to die from a preventable disease.' Distributed by APO Group on behalf of Médecins sans frontières (MSF).
Zawya
2 days ago
- Zawya
Protecting the future: annual review meeting of Ethiopia's The Ethio-Pandemic Prevention, Preparedness and Response (EPPR) project
The Ethio-Pandemic Prevention, Preparedness and Response (EPPR) Project held its first Annual Review Meeting from 9 to 11 July 2025 in Bishoftu, Ethiopia. The review brought together high-level government officials, technical experts, UN representatives, and other partners committed to advancing Ethiopia's pandemic preparedness through a unified One Health approach. Participants included representatives from the Ministry of Health, Ministry of Agriculture, Ethiopian Public Health Institute (EPHI), Animal Health Institute (AHI), Armauer Hansen Research Institute (AHRI), regional bureaus, academia, UN agencies, and key development partners, including the UK Health Security Agency. The meeting was formally opened by Dr. Mebratu Masebo, on behalf of the Minister of Health, setting the tone for a high-level, collaborative exchange. Distinguished keynote speakers included H.E. Professor Afework Kassu, Director General of AHRI; H.E. Dr. Tesfaye Rufael, Director General of AHI; Dr. Patrick Okumu Abok, Team Lead, WHO Health Emergencies Programme, on behalf of the WHO Representative in Ethiopia; Ms. Farai Zimudzi, FAO Country Representative; and Dr. Daniel Ngemera from UNICEF Ethiopia. Their opening remarks underscored the urgency and importance of cross-sectoral collaboration in pandemic risk management. A gallery walk showcased key achievements from the first year of implementation, highlighting the project's strong alignment with national One Health priorities. The interactive exhibition gave stakeholders a visual and experiential understanding of interconnected activities and progress made across sectors. Leaders from human and animal health sectors, development partners, and academic institutions engaged with the displays, recognizing Ethiopia's growing role as a regional leader in pandemic preparedness. Implementing and delivery partners presented the project's accomplishments, reflecting a year of determination, innovation, and resilience. Despite early implementation challenges, the EPPR Project has demonstrated measurable results and earned broad praise from government officials and partners. Ethiopia is increasingly regarded as a global example of how pandemic preparedness can be integrated across sectors to build a strong, responsive health system. Year Two priorities, developed and refined by the project's Technical Working Groups (TWGs), were shared with the broader stakeholder group to ensure alignment, ownership, and accountability. The revised workplan emphasizes accelerating regional implementation, deepening local capacity, and strengthening cross-sector coordination. Three thought-provoking panel discussions provided opportunities for deeper reflection and forward-looking dialogue: The first panel, led by H.E. Dr. Melkamu Abte, focused on EPPR's contribution to Ethiopia's national emergency preparedness and response system. The second, moderated by Dr. Feyesa Regassa, addressed One Health integration and cross-sector collaboration. The third, led by Dr. Shahira Ahmed Malm, explored strategies for sustainable resource mobilization and co-investment. These expert discussions generated actionable insights and strategic ideas to guide the project's future direction. The meeting's outcomes reflect not only the national progress made, but also the growing significance of Ethiopia's leadership in the global pandemic preparedness arena. Supported by the Pandemic Fund—launched at the G20 Leaders' Summit in Bali and hosted by the World Bank Group with WHO as technical lead—the EPPR Project stands as a flagship example of how global financing and national ownership can converge to address one of the most pressing public health challenges of our time. With a shared vision and collective determination, stakeholders reaffirmed their commitment to continue building a safer, healthier, and more prepared Ethiopia. The meeting concluded with clear commitments for the next phase of the project. Stakeholders agreed on the importance of documenting experiences through policy briefs and scientific publications; trengthening coordination platforms to avoid duplication and build synergy and Jointly mobilizing resources through a One Health financing approach. The other actions agreed on were promoting knowledge sharing via webinars, gallery walks, and field visits, deepening partnerships with academia to support research and training, and Mapping and registering trained workforce members for rapid deployment during emergencies, aligning technical expertise with regional needs. Project leadership emphasized the need to reassess the pace of implementation, increase regional engagement, and ensure tangible impact at the community level. Sustained leadership commitment, strategic advocacy, and a culture of shared accountability across sectors will be critical to maintaining momentum and achieving long-term success. Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Zawya
2 days ago
- Zawya
Sustaining efforts to end mpox outbreaks in Africa
One year since World Health Organization (WHO) declared mpox a Public Health Emergency of International Concern (PHEIC), African countries have scaled up response measures and made progress to curb the spread of the virus. Coordinated action between governments, WHO, Africa Centre for Disease Control and Prevention (Africa CDC), communities and partners has helped strengthen disease surveillance, expand laboratory testing, roll out vaccination and improve treatment and care of people with mpox. Mpox remains a serious public health challenge in Africa. In the past year, 28 African countries have been affected, with more than 174 000 suspected and nearly 50 000 confirmed cases reported. Around 240 lives have been lost. However, response efforts are paying off. In the last six weeks, the weekly number of confirmed cases declined by 34.5% compared with the preceding six weeks. Over 3 million doses, almost half of the target have been delivered, more than 951 000 doses administered and around 900 000 people vaccinated with at least one dose. Thanks to sustained efforts, Cote d'Ivoire, for instance, has brought its outbreak under control after 42 days with no new cases. Angola, Gabon, Mauritius, and Zimbabwe have also gone more than 90 days without any new confirmed cases. 'Our collective efforts have been crucial in strengthening measures for an effective response,' said Dr Otim, Patrick Ramadan Programme Area Manager, Emergency Response at WHO Regional Office for Africa. 'It is critical to sustain what works, which includes rapid case detection, timely targeted vaccination, strong laboratory systems, and active community engagement.' Collaboratively, WHO and Africa CDC have developed continental Mpox Preparedness and Response Plans and co-led the implementation through continental Incident Management Support Team in collaboration with partners. 'The partnership between Africa CDC and WHO highlights strong African leadership. With limited resources, there is a critical need to be more efficient which means working as one team, with one plan budget and monitoring framework,' said Professor Yap Boum, Deputy Continental Incident Manager for Africa CDC Since August 2024, WHO has worked closely with countries to boost response capacity. Thirteen of the 22 countries with active transmission now have vaccine deployment plans, and eight are vaccinating high-risk groups and contacts. However, challenges persist. These include limited access to vaccines, competing emergencies, funding gaps, inadequate access to care, and stigma that keeps people from seeking care. Conflict in eastern Democratic Republic of the Congo continues to disrupt response efforts. 'Our priorities for the next six months are to expand community-based surveillance in high-risk areas, continue to procure and distribute essential supplies to hotspots, support the integration of mpox response into other health programs for sustainability, support targeted vaccination and advocate for more funding for vaccine deployment,' said Dr Otim. Distributed by APO Group on behalf of WHO Regional Office for Africa.
